Quantcast
Home > Quotes > CORI
CORI

Corium International, Inc. Common Stock (CORI) Quote & Summary Data

$9.4
*  
0.36
3.98%
Get CORI Alerts
*Delayed - data as of Sep. 21, 2018  -  Find a broker to begin trading CORI now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 9.62 / $ 9.03
Share Volume
252,237
50 Day Avg. Daily Volume
214,123
Previous Close
$ 9.04
52 Week High / Low
$ 13.93 / $ 7.17
Market Cap
340,752,453
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

News for CORI

Shares Traded

Share Volume:
252,237
50 Day Avg. Daily Volume:
214,123

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.57

Trading Range

The current last sale of $9.40 is 31.10% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 9.62 $ 13.93
 Low: $ 9.03 $ 7.17

Company Description (as filed with the SEC)

We are a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage our broad experience with advanced transdermal and transmucosal delivery systems. We have multiple proprietary programs in preclinical and clinical development focusing primarily on the treatment of neurological disorders, with two lead programs in Alzheimer's disease. We have developed and are the sole commercial manufacturer of seven prescription drug and consumer products for our marketing partners. We have two proprietary transdermal platforms: Corplex(TM) for small molecules and MicroCor®, a biodegradable microstructure technology for small molecules and biologics, including vaccines, peptides and proteins.  ... More ...  


Risk Grade

Where does CORI fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 9.03
Open Date:
Sep. 21, 2018
Close Price:
$ 9.04
Close Date:
Sep. 21, 2018

Consensus Recommendation

Analyst Info